Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
Phase I Study of HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma (HEROS 3.0)
The purpose of this study is to learn whether it is safe to give HER2-CAR T cells in combination with an immune checkpoint inhibitor drug (pembrolizumab or niv…
SarcomaHER-2 Protein OverexpressionOsteosarcoma+5 more
Baylor College of MedicineNCT04995003
Phase 1
Lurbinectedin in FET-Fusion Tumors (LIFFT)
The purpose of this study is to find out if a drug called lurbinectedin (the "study drug") is safe and effective at treating people with recurrent or relapsed …
Ewing SarcomaDesmoplastic Small Round Cell TumorPediatric Cancer+1 more
Children's Hospital of PhiladelphiaNCT05918640